Or. Admin. Code § 855-139-0010

Current through Register Vol. 63, No. 12, December 1, 2024

Section 855-139-0010 - Registration: General

(1) A location in Oregon where the practice of pharmacy occurs by an Oregon licensed Pharmacist through the use of a telepharmacy system to a patient at a remote location staffed by a Certified Oregon Pharmacy Technician or Pharmacy Technician must be registered by the board in Oregon as a Retail Drug Outlet RDSP.

(2) If controlled substances are stored in the RDSP, the RDSP must have an active Controlled Substance Registration Certificate with the board and Drug Enforcement Administration (DEA).

(3) The Retail Drug Outlet RDSP application must specify the RDSP Affiliated Pharmacy and cannot operate without a RDSP Affiliated Pharmacy that is registered by the board as a Retail Drug Outlet Pharmacy.

(4) All registration renewal applications must be accompanied by the annual fee and must contain the same information required in OAR 855-139-0015(2).

(5) The initial and annual registration fee for pharmacies is set out in OAR 855-110.

(6) The Retail Drug Outlet RDSP registration expires March 31, annually. If the annual registration fee referred to in OAR 855-110 is not paid by March 31 of the current year, a late fee as set out in OAR 855-110 must be included with the application for registration renewal.

(7) The registration is not transferable and the registration fee cannot be prorated.

(8) No RDSP may be operated until a certificate of registration has been issued to the pharmacy by the board.

Or. Admin. Code § 855-139-0010

BP 43-2021, adopt filed 12/16/2021, effective 01/01/2022; BP 1-2022, minor correction filed 01/03/2022, effective 01/03/2022; BP 9-2022, minor correction filed 01/05/2022, effective 1/5/2022; BP 26-2022, temporary amend filed 04/22/2022, effective 4/22/2022 through 10/18/2022; BP 36-2022, amend filed 06/15/2022, effective 6/16/2022

Statutory/Other Authority: ORS 689.205, ORS 689.700 & 2022 HB 4034

Statutes/Other Implemented: ORS 689.151, ORS 689.155, ORS 689.225, ORS 689.700 & 2022 HB 4034